Administrative Law, Personal Injury, Products Liability

Actos: Blowing the Whistle

by Phillips Law Offices on 1/18/2013

The drug pioglitazone, marketed as Actos®, is prescribed to treat type 2 diabetes. Chemically related to the diabetes drug Avandia, Actos has come under fire in recent years for serious, sometimes fatal side effects....more

What Makes Side Effects Actionable?

by Phillips Law Offices on 1/11/2013

With increasing profits to be made in drug development and manufacturing and escalating reliance upon pharmaceutical treatment by the medical community, it seems that new drugs are entering the market every day to treat every...more

Transvaginal Mesh Multi District Litigation

by Phillips Law Offices on 12/26/2012

Transvaginal mesh is a synthetic fiber sling that is implanted through the vagina. It is used to prevent instances of pelvic organ prolapse in women, a condition in which organs such as the bladder, uterus, and lower...more

Product Liability Law Medical Device Law Update: December 2012 - “A State of Profound Uncertainty”: The Crisis in Pennsylvania

by S. Vance Wittie | Sedgwick LLP on 12/24/2012

Since the mid-1960s, Pennsylvania has adhered to the strict liability tenets of section 402A of the Restatement (Second) of Torts. Its version of strict liability had a number of unique features, including the determination...more

Meningitis Outbreak Spawns Dicey Treatment Claims

by Patrick Malone & Associates P.C. | DC Injury... on 11/20/2012

Meningitis—a life-threatening inflammation of the membranes surrounding the brain and spinal cord—has seldom been more prominent in the news, and for all the wrong reasons. The contaminated steroid made and distributed by a...more

INSIGHTS - Patton Boggs Safety & Health and Crisis Management Newsletter - October 2012

by Patton Boggs LLP on 10/12/2012

In This Issue: 1. Rockefeller Reintroduces Mine Reform Legislation 2. Whistleblower Protections Added to Highway Bill 3. GAO Endorses Studies Supporting Black Lung Rule 4. Demolition, Underground Construction...more

Pharmaceutical Law Update -- October 2012: New Jersey Court Grants Summary Judgment Based on Lack of Warning Causation

by Sedgwick LLP on 10/4/2012

A New Jersey federal court granted summary judgment to Baxter Healthcare Corporation (Baxter) last month based on a familiar legal concept rarely applied in the Garden State – warning causation. In Baker et al. v. APP...more

Insurance Coverage for Food and Beverage Contamination

by King & Spalding on 9/5/2012

Damages owed from illness and death claims resulting from actual or alleged food and beverage contamination, along with the cost of recalls of potentially contaminated products, present serious financial risk to companies...more

Tarion Overhaul of Major Structural Defect Procedures

by Heenan Blaikie LLP on 7/18/2012

Tarion has introduced significant changes to the major structural defect claims process. These changes will affect all condominium projects where the first arm’s length agreement of purchase and sale was signed after July 1,...more

Should Brake-Override Systems in Cars be Mandatory?

by Howard Ankin on 4/19/2012

Are brake-override systems necessary? Should they be mandatory for all new vehicles? Federal regulators seem to think so. In fact, the National Highway Traffic Safety Administration just recently proposed that all automobile...more

Female Crash Test Dummies Now Regularly Being Used

by Howard Ankin on 4/17/2012

It may surprise you to learn that it wasn’t until 2003 that the National Highway Traffic Safety Administration (NHTSA) began to sometimes use female crash test dummies when simulating crashes to determine the safety of...more

FDA Announces Propecia, Proscar to Receive New Sexual Dysfunction & Side Effects Warning Label

by Schmidt & Clark, LLP on 4/13/2012

Two of pharmaceutical giant Merck’s best-selling drugs, Propecia and Proscar, will be required to carry warnings linking them to severe persistent sexual side effects, the U.S. Food & Drug Administration (FDA) announced...more

Birth Control Blood Clot Risk Prompts FDA to Issue Drospirenone Label Change

by Schmidt & Clark, LLP on 4/11/2012

April 10, 2012 - The U.S. Food & Drug Administration (FDA) issued a press release today stating that it had completed a review of epidemiological studies regarding the risk of blood clots in women taking birth control pills...more

How much should automakers be fined for not complying with recall rules?

by Howard Ankin on 4/5/2012

In late March, the United States Senate approved legislation that would increase the fines levied against U.S. automakers who failed to comply with automobile recall regulations. Currently, automakers are fined a maximum of...more

Diabetes Warning Issued for Statin Drugs

by Patrick Malone & Associates P.C. | DC Injury... on 3/12/2012

A class of drugs called statins lowers blood cholesterol levels by reducing the production of cholesterol by the liver. Lipid regulators, which are primarily statin drugs, are the most commonly prescribed medication in the...more

Court of Appeals Affirms Dismissal of FEMA Trailer Claims

by Dechert LLP on 1/30/2012

The Fifth Circuit last week upheld the dismissal of putative class actions filed by Mississippi and Alabama residents against the federal government alleging trailers provided to Hurricane Katrina-impacted citizens contained...more

FDA Must Improve Monitoring of Food Safety

by Patrick Malone & Associates P.C. | DC Injury... on 1/12/2012

According to a report by the Department of Health and Human Services, every year 128,000 Americans are hospitalized and 3,000 die from food poisoning. The FDA is responsible for safeguarding the food supply and for inspecting...more

Another Warning on Baby Acetaminophen (Tylenol)

by Patrick Malone & Associates P.C. | DC Injury... on 12/27/2011

If you give your baby acetaminophen to reduce fever and pain, pay close attention to the packaging. Several months ago, we reported about the FDA’s interest in more accurate dosing information for children’s Tylenol ....more

Presumption-of-Adequacy Defense Is Clarified and Reinforced

by Duane Morris LLP on 12/20/2011

On Sept. 29, the Appellate Division took a significant step forward in clarifying and reinforcing the presumption-of-adequacy defense provided to manufacturers of prescription drugs under the New Jersey Product Liability Act...more

Two New PMA Preemption Cases

by Dechert LLP on 12/8/2011

You all know we love preemption. So, when two favorable medical device preemption decisions are entered on the same day, well that’s a two-fer we can’t wait to blog about. In both cases, plaintiffs tried to plead and argue...more

Study Shows No Advantage to Metal Hip Replacements

by Patrick Malone & Associates P.C. | DC Injury... on 12/6/2011

A new study in BMJ , the British medical journal, has revived interest in the issue of the kind of materials best used for hip replacements. Problems have long been reported from many quarters when metal is used to...more

Youth and Tanning Beds: Do Not Mix

by Patrick Malone & Associates P.C. | DC Injury... on 10/18/2011

The groundswell against the use of tanning beds got an additional boost last week when California Gov. Jerry Brown signed legislation prohibiting children younger than 18 from using the body-bronzers as of January 2012....more

FDA Issues a Warning for Avastin – Again

by Patrick Malone & Associates P.C. | DC Injury... on 10/15/2011

The problems with the cancer drug Avastin are never ending. The FDA has issued a another warning about the drug’s dangers, this time involving ovarian failure, jaw necrosis (bone decay), blot clots and excessive...more

Bills Introduced to Halt New Federal Regulations

by Dechert LLP on 9/23/2011

We from time to time have called our readers attention to developments in the important field of tort reform. While often this takes the form of state legislation affecting substantive legal doctrine, there is another...more

Consumers Seek Recall of Brazilian Blowout

by Patrick Malone & Associates P.C. | DC Injury... on 9/16/2011

It sounds like a World Cup Soccer match result, but in fact, Brazilian Blowout is a hair-straightening product. And thanks to a wave of unpleasant responses to its use, the FDA has issued a warning letter to its...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

Administrative Law › Personal Injury › Products Liability